human prothrombin complex
PolandDrugs containing this active substance
-
The medicinal product is used for the treatment and prevention of bleeding caused by congenital or acquired deficiency of vitamin K-dependent blood clotting factors. It is also used during surgical procedures.
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human prothrombin complex 1000 j.m. ATC: B02BD01
Manufacturer: CSL Behring GmbH
-
The medicinal product is used for the treatment and prevention of bleeding caused by vitamin K antagonist therapy (e.g., warfarin) when rapid correction of deficiency is required. It is also used in individuals born with deficiencies of clotting factors II and X when a specific factor product is unavailable.
Form: powder and solvent for preparation of infusion solution
Active substance Dosage human prothrombin complex 1000 j.m. ATC: B02BD01
Manufacturer: Octapharma Pharmazeutika Produktionsgesellschaft mbH (OPG)
-
The medicine is used for the treatment of bleeding, the prevention of bleeding immediately before and after surgery, and in cases of congenital or acquired deficiency of blood clotting factors.
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human prothrombin complex 500 j.m. ATC: B02BD01
Manufacturer: Takeda Manufacturing Austria AG